Immunocore Holdings (IMCR)

Immunocore Holdings Stock Analysis & Ratings

IMCR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$18.43 - $42.25
Previous Close$29.8
Average Volume (3M)189.65K
Market Cap$1.31B
P/E RatioN/A
Next EarningsAug 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score4
EPS (TTM)0.00

Immunocore Holdings News

Currently, no data available
Please return soon. This page is being updated.




P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Immunocore Holdings’s price range in the past 12 months?
Immunocore Holdings lowest stock price was $18.43 and its highest was $42.25 in the past 12 months.
    What is Immunocore Holdings’s market cap?
    Immunocore Holdings’s market cap is $1.31B.
      What is Immunocore Holdings’s price target?
      The average price target for Immunocore Holdings is $60.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $80.00 ,the lowest forecast is $45.00. The average price target represents 101.34% Increase from the current price of $29.8.
        What do analysts say about Immunocore Holdings?
        Immunocore Holdings’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Immunocore Holdings’s upcoming earnings report date?
          Immunocore Holdings’s upcoming earnings report date is Aug 10, 2022 which is in 85 days.
            How were Immunocore Holdings’s earnings last quarter?
            Immunocore Holdings released its earnings results on May 11, 2022. The company reported -$0.457 earnings per share for the quarter, beating the consensus estimate of -$1.043 by $0.586.
              Is Immunocore Holdings overvalued?
              According to Wall Street analysts Immunocore Holdings’s price is currently Undervalued.
                Does Immunocore Holdings pay dividends?
                Immunocore Holdings does not currently pay dividends.
                What is Immunocore Holdings’s EPS estimate?
                Immunocore Holdings’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Immunocore Holdings have?
                Immunocore Holdings has 43,900,000 shares outstanding.
                  What happened to Immunocore Holdings’s price movement after its last earnings report?
                  Immunocore Holdings reported an EPS of -$0.457 in its last earnings report, beating expectations of -$1.043. Following the earnings report the stock price went down -12.237%.
                    Which hedge fund is a major shareholder of Immunocore Holdings?
                    Among the largest hedge funds holding Immunocore Holdings’s share is Omega Fund Management, LLC. It holds Immunocore Holdings’s shares valued at 2M.


                      Immunocore Holdings Stock Analysis

                      The Immunocore Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Immunocore Holdings

                      Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases.

                      Similar Stocks
                      No data currently available

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis